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Left ventricular isovolumic relaxation and the relation 
between relaxation and filling were studied in 90 patients 
with hypertrophic cardiomyopathy and 29 control sub•
jec~s using radionuclide angiography. The isovolumic 
relaxation period was determined automatically on left 
ventricular time-activity curves as the interval between 
minimal volume and onset of rapid filling. In 17 patients, 
M-mode echocardiography performed simultaneously with 
radionuclide angiography demonstrated that onset of 
mitral valve opening correlated well with onset of rapid 
filling (r = 0.84, p < 0.001). 
The isovolumic relaxation period was longer in pa•
tients with hypertrophic cardiomyopathy than in control 
subjects (95 ± 44 versus 50 ± 23 ms, p < 0.01) and 
was longer in patients without an outflow tract gradient 
at rest than in patients with a gradient (109 ± 37 versus 
86 ± 35 ms, p < 0.05). In these patients without ob•
struction, a weak linear relation between duration of the 
isovolumic period and peak filling rate was fodnd (r = 
0.48, p < 0.02). Filling was impaired in patients with 
hypertrophic cardiomyopathy, as assessed by lower peak 
filling rate (3.2 ± 1.2 versus 3.5 ± 0.5 end-diastolic 
Impaired left ventricular diastolic function in hypertrophic 
cardiomyopathy, with or without associated left ventricular 
outflow tract obstruction, is a major determimmt of patho•
physiologic abnormalities and symptoms. Both relaxation 
(1-6) and filling (1,2,4,5,7-11) of the left ventricle are 
decreased in this disease. These abnormalities are related 
because the reduced rate and extent of diastolic filling may 
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volume/s, p < 0.05) and prolonged time to peak filling 
rate (185 ± 44 versus 145 ± 20 ms, p < 0.01) compared 
with values in control subjects. The delay in time to peak 
filling rate was caused primarily J,y the prolonged iso•
volumic period, because the interval from onset of rapid 
filling to peak filling rate was similar in patients with 
hypertrophic cardiomyopathy and control subjects (87 
± 31 versus 95 ± 25 ms, NS). Studies were repeated 
in 43 patients after administration of oral verapamil (320 
to 640 mg/day). Verapamil decreased the isovolumic re•
laxation period (from 95 ± 42 to 80 ± 31 ms, p < 0.05), 
associated with improved filling; peak filling rate in•
creased and time to peak filling rate decreased. 
Thus, the delay in peak filling rate in patients with 
hypertrophic cardiomyopathy is caused by prolongation 
of the isovolumic period. Verapamil decreases the iso•
volumic relaxation perioll and improves subsequent di•
astolic filling. These data suggest that impaired relax•
ation is an important determinant of decreased left 
ventricular filling in patients with hypertrophic car•
diomyopathy. 
(J Am Coli CardioI1986;7:74-81) 
reflect increased myocardial tone during diastole resulting 
from prolonged or incomplete relaxation. 
Noninvasive clinical evaluation of isovolumic relaxation 
has usually been performed with M-mode echocardiog•
raphy, with the isovolumic relaxation period measured as 
the time interval between end-systole and mitral valve open•
ing (3-6). In this study we assessed the isovolumic relax•
ation period in patients with hypertrophic cardiomyopathy 
using high temporal resolution time-activity curves derived 
by radionuclide angiography. Because radionuclide angi•
ography provides left ventricular volume data that are in•
dependent of geometry, it has advantages over M-mode 
echocardiography in evaluating left ventricular filling in hy•
pertrophic cardiomyopathy, in which morphologic inho•
mogeneity and irregular cavity shape may make interpre•
tation of one-dimensional observations difficult or invalid. 
Therefore, we studied the relation between prolonged left 
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ventricular relaxation and subsequent diastolic filling in pa•
tients with hypertrophic cardiomyopathy both with and with•
out an outflow tract gradient. We also evaluated the effects 
of verapamil in a subset of patients. 
Methods 
Patient selection. We studied 100 patients with hyper•
trophic cardiomyopathy aged 20 to 65 years (mean 55). 
There were 65 men and 35 women. The diagnosis of hy•
pertrophic cardiomyopathy was based on echocardiographic 
demonstration of a nondilated hypertrophied left ventricle 
in the absence of another cardiac or systemic disease capable 
of producing myocardial hypertrophy (12). All patients were 
in normal sinus rhythm and all were studied after cardiac 
drugs were withdrawn for at least 48 hours; none had under•
gone previous cardiac surgery. 
We also studied 33 normal control subjects aged 26 to 
51 years (mean 45). There were 22 men and 11 women. 
Seventeen subjects were normal volunteers without evidence 
of cardiovascular disease. The other 16 were patients eval•
uated because of a history of chest pain. All subjects in this 
latter group underwent coronary arteriography, which dem•
onstrated normal coronary arteries. In addition, these pa•
tients had no evidence of cardiovascular disease on physical 
examination (including blood pressure measurements), elec•
trocardiogram, chest X-ray film and M-mode echocardio•
gram; radionuclide angiography demonstrated normal left 
ventricular ejection fraction at rest, normal ejection fraction 
response to exercise and no regional wall motion abnor•
malities. 
Radionuclide angiography. Radionuclide angiography 
was performed at rest inthe supine position. Red blood cells 
were labeled in vivo with 15 to 20 mCi of technetium-99m 
(13). Imaging was performed with a conventional Anger 
camera equipped with a high sensitivity, parallel-hole col•
limator oriented in a modified left anterior oblique projection 
to isolate the left ventricle from other cardiac structures. 
A sequence of cardiac images, spanning the average car•
diac cycle, was constructed from several hundred cardiac 
cycles by computer-based electrocardiographic gating, us•
ing list-mode data acquisition (9,14) and combined forward 
and reverse gating from the R wave (15,16), High tefTIporal 
resolution (10 to 20 ms/frame) left ventricular time-activity 
curves were generated from left ventricular and background 
regions of interest. Studies with average cycle lengths greater 
than 660 ms were framed at a rate of 50/s (20ms/frame), 
while those with cycle lengths of 660 ms or less were framed 
at a rate of 100/s (lOms/frame). Time to end-systole was 
measured from the R wave to the nadir of the time-activity 
curve. Peak filling rate was measured as the maximal slope 
of a third order polynomial function that was fit to the rapid 
filling phase of the curve using a least squares technique 
(17). Time to peak filling rate was defined as the time 
interval between end-systole and the peak filling rate. 
Most time-activity curves constructed by this technique 
have a visually apparent isovolumic rdaxation period (Fig. 
1), characterized by an interval after minimal left ventricular 
volume with a horizontal or slightly positive slope. This 
period is terminated by the onset of rapid diastolic filling, 
represented by an inflection point followed by an abrupt 
increase in slope. this inflection point terminating the iso•
volumic period was identified automatically as follows: the 
time-activity curve was filtered using a Fourier expansion 
with four harmonics and the second derivative of this filtered 
curve was evaluated at each point. The first maximum on 
the second derivative curve occurring between end-systole 
and the time of peak fillirtg rate was considered to be the 
inflection point marking onset of rapid filling (Fig. 1). An 
Figure 1. A, Raw time-activity curve of a patient with hyper•
trophic cardiomyopathy. The isovolumic relaxation period (IRP) 
is apparent. B, Time-activity curve of the same patient after Fourier 
filtering using four harmonics. C, Second derivative curve derived 
from the filtered curve in B. A maximum after end-systole (ES) 
is present on the derivative curve (arrow) and corresponds to the 
termination of the isovolumic period in A and B. Each point 
represents 20 ms. EDV = end-diastolic volume. 
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algorithm was designed to measure automatically the time 
interval from the R wave to this inflection point. From this 
time interval, time to end-systole was subtracted and the 
resulting value was defined as the isovolumic relaxation 
period. The isovolumic period could be computed in this 
manner in 29 (88%) of 33 control subjects and 90 (90%) 
of 100 patients with hypertrophic cardiomyopathy. In the 
other 14 (11 %) of these 133 curves, a maximum on the 
second derivative curve did not occur between end-systole 
and the peak filling rate. These patients are excluded from 
subsequent analysis, and the results pertain to data in the 
remaining 89% of subjects. 
Cardiac catheterization. Forty-five of the 90 patients 
with hypertrophic cardiomyopathy underwent diagnostic 
cardiac catheterization within 30 days of radionuclide an•
giography. The mean interval between the two studies was 
7 ± 8 days (range 0 to 28). Patients were considered to 
have subaortic obstruction under basal conditions at rest 
when a left ventricular outflow tract gradient of 30 mm Hg 
or more was present. 
Verapamil therapy. Forty-three of the 90 patients with 
hypertrophic cardiomyopathy, all moderately to severely 
symptomatic, underwent a second radionuclide angio•
graphic study after initiation of oral verapamil therapy. 
Administration of verapamil was begun at a dose of 240 
mg/day in divided doses and was gradually increased every 
36 to 48 hours to a dose of 480 to 640 mg/day. The final 
verapamil dose in each patient was determined by clinical 
response and was limited in some patients by atrioventricular 
(A V) dissociation, Mobitz I second degree A V block or 
systemic hypotension. 
Echocardiography. In 17 additional patients with hy•
pertrophic cardiomyopathy, M-mode echocardiography was 
performed simultaneously with radionuclide angiography to 
correlate the temporal relation between mitral valve opening 
as identified by echocardiography and the beginning of rapid 
filling as assessed by radionuclide angiography. Immedi•
ately after completion of radionuclide data acquisition, an 
M-mode echocardiogram and simultaneous lead II electro•
cardiogram were obtained with standard techniques. When 
a satisfactory image of the mitral valve was achieved, show•
ing both leaflets and clear definition of leaflet separation in 
early diastole, at least 15 cardiac cycles were recorded at a 
paper speed of 100 mm/s. Among 15 consecutive beats, the 
10 cycles showing the clearest definition of mitral valve 
opening were selected. The interval from the R wave to the 
onset of mitral valve opening was measured for each of the 
10 cycles and averaged. This interval was then compared 
with the time corresponding to onset of rapid filling mea•
sured on the time-activity curves. 
Reproducibility. The reproducibility of time to end-sys•
tole, peak filling rate and time to peak filling rate measure•
ments in patients with hypertrophic cardiomyopathy has 
been reported previously (9). Seventeen patients with hy-
pertrophic cardiomyopathy were studied twice to determine 
reproducibility in identifying the transition from isovolumic 
phase to rapid filling. Two radionuclide angiograms were 
performed at rest after a single dose of technetium-99m. 
Statistical methods. Paired and unpaired t tests were 
used where appropriate (18); the dependence of peak filling 
rate on isovolumic relaxation period was assessed by linear 
regression analysis (18). Comparison of data between nor•
mal control subjects and patients with hypertrophic cardio•
myopathy with and without an outflow tract gradient at rest 
was performed by analysis of variance. The difference in 
the incidence of prolonged isovolumic relaxation periods in 
patients with or without left ventricular outflow tract ob•
struction was tested by chi-square analysis using Yates' 
correction for continuity (19). For both echocardiographic 
validation and reproducibility of radionuclide angiographic 
measurements, the mean and standard deviation of two mea•
surements Were computed; the coefficient of variation of 
that particular observation was obtained by dividing the 
standard deviation by the mean and mUltiplying by 100 (20); 
the average value of the coefficients of variation was then 
calculated. 
Results 
Echocardiographic and radionuclide angiographic 
data. The time intervals between the R wave and mitral 
valve opening on echocardiograms, and between the R wave 
and onset of rapid filling on radionuclide angiograms, were 
linearly related (y = 0.99x + 11; r = 0.84; P < 0.001) 
and the fitted line did not differ from the line of identity. 
The mean values of these echocardiographic and radio•
nuclide time intervals were not significantly different (467 
± 58 and 478 ± 69 ms, respectively). The absolute dif•
ference between the two measurements, expressed as a per•
cent of the radionuclide values, ranged from 0 to 19% (me•
dian 5%, mean 6 ± 4%). The average coefficient of variation 
between the two measurements was 5 ± 3% (range 0 to 
13%). 
Reproducibility. In 17 patients studied twice, the time 
interval between the R wave and the beginning of rapid 
filling showed a close correlation in the two studies (y = 
0.94x + 24; r = 0.92; P < 0.001) and the fitted line did 
not differ from the line of identity. The mean values of these 
time intervals were not significantly different in the two 
studies (449 ± 58 and 447 ± 60 ms) and their percent 
difference ranged from 0 to 13% (median 4%, mean 4 ± 
4%). The average coefficient of variation was 3 ± 3%, 
with 0 and 9% its extreme values. 
Time to end-systole related closely in the two studies (y 
= 0.76x + 75; r = 0.91; p < 0.001) and the fitted line 
did not differ significantly from the line of identity. The 
mean values of these time intervals were not significantly 
different in the two studies (355 ± 54 and 346 ± 45 ms), 
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Table 1. Radionuclide Measurements in Normal Subjects and in Patients With Hypertrophic Cardiomyopathy 
PatIent, With HypertrophIC CardIOmyopathy 
Normal All 
Cathetenzed PatIents 
Subjects Patient, No Ob,truction Obstruction p Value 
No. of patient, 29 90 26 19 
Cardiac cycle length (ms) 839 ± 136 835 ± 156 888 ± lSI 837 ± 146 NS 
Time to end-systole (ms):!: 340 ± 32 360 ± 44* 349 ± 45 373 ± 25t < 0.05 
Time to onset of rapid filling (ms):!: 389 ± 31 456 ± 49t 458 ± 54t 459 ± 36t NS 
Peak filling rate (EDV/s) 3.5 ± 0 5 3 2 ± 1.2* 3.2 ± 1.2 3.4 ± 1.2 NS 
Time to peak filling rate (ms)§ 145 ± 20 185 ± 44t 193 ± 34t 182 ± 39t NS 
Isovolumic relaxatIOn time (ms)§ 50 ± 23 95 ± 44t 109 ± 37t 86 ± 35t < 0.05 
Time from onset of rapid filling to 95 ± 25 87 ± 31 83 ± 27 96 ± 37 NS 
peak filling rate (ms) 
Statistical difference compared with nonnal: * p < 0.05; t p < 001 tMeasured from R wave, §measured from end-systole. EDV = end-diastolic 
volume. 
with their percent change ranging from 0 to 13% (median 
5%, mean 4 ± 4%). The coefficient of variation between 
the two measurements ranged from 0 to 9% (mean 4 ± 
3%), 
Isovolumic relaxation period. Table I illustrates the 
differences in the indexes of left ventricular relaxation and 
filling between the control subjects and the patients with 
hypertrophic cardiomyopathy, The cycle length was not dif•
ferent in the two groups, End-systole was significantly de•
layed in the patients with hypertrophic cardiomyopathy, as 
was the beginning of rapid filling. The isovolumic relaxation 
period was also significantly longer in these patients. peak 
filling rate was slightly but significantly lower and time to 
peak filling rate was longer than in the control group. The 
Figure 2. Time-activity curves of a patient without (left) and a 
patient with (right) a left ventricular outflow tract gradient at the 
time of cardiac catheterization. These patients had similar RR 
intervals (850 and 900 ms, respectively) and peak filling rates (3.9 
and 4.0 end-diastolic volumes/so respectively) and times to onset 
of rapid filling (460 ms for both), whereas time to end-systole was 
shorter in the patient without obstruction (340 compared with 400 
ms). Thus, isovolumic relaxation periods (IRP) were different (120 
and 60 ms, respectively), Abbreviations as in Figure I. 
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time interval between the end of the isovolumic period and 
the occurrence of peak filling rate (calculated as the differ•
ence between time to peak filling rate and the isovolumic 
relaxation period), however, did not differ significantly in 
patients with hypertrophic cardiomyopathy and normal 
subjects. 
Influence of left ventricular obstruction. The 45 pa•
tients who underwent cardiac catheterization within 30 days 
of radionuclide angiography were analyzed as a separate 
subgroup (Table I). In patients with basal obstruction, time 
to end-systole was prolonged, whereas onset of rapid filling 
occurred at similar times in both subgroups of patients, those 
with or without obstruction. As a consequence, the isovo•
lumic relaxation period was significantly shorter in patients 
with than in patients without obstruction at rest (Table I, 
Fig. 2). Peak filling rate and time to peak filling rate were 
not different between the two subgroups. Peak filling rate 
was significantly related to the isovolumic relaxation period 
only in patients without a left ventricular outflow tract gra•
dient. Even in these patients, however, the correlation coef•
ficient was not very high (r = 0.48). 
Effect of verapamil. Oral verapamil administration in 
43 patients significantly decreased the isovolumic period 
(Table 2), This was associated with a significant improve-
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Table 2. Effect of Verapamil on Left Ventricular Relaxation and Filling in 43 Patients With 
Hypertrophic Cardiomyopathy 
Control Verapamll p Value 
Cardiac cycle length (ms) 845 :t 159 891 :t 135 NS 
Time to end-systole (ms) 366 :t 42 359 :t 28 NS 
Time to onset of rapid filling (ms) 461 :t 37 440 :t 36 < 0.01 
Peak filling rate (EDV/s) 3.4 :t 1.2 4.1 :t 1.1 < 0.01 
Time to peak filling rate (ms) 183 :t 44 166 :t 27 < 0.05 
Isovolumic relaxation time (ms) 95 :t 42 80 ± 31 < 0.05 
Time from onset of rapid filling 85 :t 31 86 :t 16 NS 
to peak filling rate (ms) 
Abbreviations and measurements as in Table I. 
ment in rapid diastolic filling: peak filling rate increased and 
time to peak filling rate was decreased. The time interval 
between the end of the isovolumic relaxation period and the 
occurrence of peak filling rate, however, was not affected 
by the drug (Table 2). 
Figure 3 and Table 3 show the effect of verapamil in 
patients with a normal or short isovolumic period (left panel) 
or a prolonged period (right panel) in the baseline study. 
Prolonged isovolumic relaxation periods were decreased by 
verapamil; in contrast, in patients with short or normal base•
line values, duration of the isovolumic relaxation period 
was increased by verapamil. This was associated with a 
decrease in time to end-systole but no change in onset of 
rapid filling. In these latter patients, however, peak filling 
rate increased, showing a similar response to that observed 
in patients with a prolonged isovolumic relaxation period 
under basal conditions. 
Discussion 
The isovolumic relaxation period. Impaired diastolic 
filling of the hypertrophied left ventricle is an important 
manifestation of hypertrophic cardiomyopathy that contrib•
utes significantly to the clinical manifestations of the dis•
ease. Abnormal filling characteristics may result, at least in 
part, from prolonged or incomplete left ventricular relax•
ation. We have demonstrated previously (9,11) that radio•
nuclide angiography is useful in characterizing the rate, 
extent and timing of the rapid diastolic filling period in 
hypertrophic cardiomyopathy. In the current investigation, 
we used this method to study the isovolumic relaxation 
period and its relation to subsequent diastolic filling. Our 
method of identifying the onset of rapid filling on the time•
activity curve (Fig. 1) reflects reasonably well the timing 
of mitral valve opening determined echocardiographically, 
with a mean coefficient of variation of 5 ± 3%. The cor•
relation between the measurements obtained by echocar•
diographic and radioisotopic techniques (r = 0.84) was very 
similar to the correlation between the cardiac cycle lengths 
recorded in the two studies (r = 0.83). Therefore, differ-
ences in the timing of mitral valve opening by echocardi•
ography and onset of rapid filling by our radionuclide method 
may result not only from methodologic limitations, but also 
from the fact that the radionuclide data were averaged over 
several hundred cycles whereas the echocardiographic val•
ues were the mean determinations of 10 cardiac cycles. 
In this study, the isovolumic relaxation period was pro•
longed in patients with hypertrophic cardiomyopathy when 
compared with control subjects (Table 1). In comparison 
with previous investigations, the isovolumic period in hy•
pertrophic cardiomyopathy obtained by our radionuclide 
method (95 ± 44 ms) was shorter than the mean value 
obtained by contrast angiographic techniques (140 ± 40 ms 
[1]) and longer than that obtained by echocardiography when 
minimal echocardiographic dimension was used to define 
the onset of isovolumic relaxation (76 ms [2]). However, 
the value was very similar to those obtained by standard 
echocardiographic techniques using aortic closure as the 
onset of the isovolumic phase (93 ± 10 ms [3]; 105 ± 40 
ms [5]; 93 ± 21 ms [21]). 
Figure 3. Effect of verapamil on isovolumic relaxation period in 
14 patients with a subnormal or normal isovolumic period (left) 
and 29 patients with a prolonged isovolumic period (right). Hor•
izontalline indicates mean normal value + 1 SD. Open circles 
with vertical bars indicate mean values ± I SD. 
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Table 3. Effect of Verapamil on Left Ventricular Relaxation and Filling in Patients With Short 
or Normal Versus Prolonged Isovolumic Relaxation Period 
Short or Normal IRP Prolonged IRP 
(n = 14) (n = 29) 
Control Verapamil p Value Control Verapamil p Value 
Cardiac cycle length 839 ± 176 897 ± 151 NS 862 ± 152 888 ± 129 NS 
(ms) 
Time to end-systole 394 ± 39 364 ± 26 < 0.05 353 ± 37 357 ± 30 NS 
(ms) 
Time to onset of rapid 444 ± 35 441 ± 33 NS 469 ± 35 439 ± 38 < 0.01 
filling (ms) 
Peak filling rate 3.5 ± 1.3 4.2 ± 1.2 < 0.01 3.3 ± 1.2 4.1 ± l.l < 0.01 
(EDV/s) 
Time to peak filling 151 ± 38 164 ± 27 NS 198 ± 39 169 ± 29 < 0.01 
rate (ms) 
Isovolumic relaxation 49 ± 13 77 ± 30 < 0.05 117 ± 33 81 ± 32 < 0.01 
period (ms) 
Time from onset of 91 ± 34 87 ± 17 NS 81 ± 30 86 ± 16 NS 
rapid filling to peak 
filling rate (ms) 
IRP = isovolumic relaxation penod; other abbreviations and measurements as in Table I. 
Limitations of radionuclide angiographic method. 
There are several limitations of our method. The onset of 
rapid filling, and hence the duration of isovolumic relax•
ation, could not be determined in 11 % of the subjects, either 
because there was statistical noise in the raw time-activity 
curve or because the transition from isovolumic to filling 
phases was too subtle to be detected automatically. In ad•
dition, the temporal resolution is relatively low at 20 ms/frame 
at most heart rates at rest. Furthermore, our method does 
not allow direct measurement of the duration of the iso•
volumic relaxation period; instead, it is computed by sub•
tracting time to end-systole from the time interval from the 
R wave to the beginning of rapid filling, and the errors 
connected with each of these primary measurements are 
additive. It should be emphasized that other measurements, 
such as time to peak filling rate, a widely used and clinically 
reliable index of diastolic filling, are analogously derived. 
Because of these potential limitations our radionuclide method 
is not intrinisically superior to the echocardiographic mea•
surement of isovolumic relaxation; however, it does provide 
reliable geometry-independent data to assess both relaxation 
and filling and the important relations between these two 
phases of diastole. 
Relation between left ventricular relaxation and fill•
ing. The prolongation of isovolumic relaxation in patients 
with hypertrophic cardiomyopathy was associated with im•
paired early diastolic filling as indicated by decreased peak 
filling rate compared with normal values (Table 1). In pa•
tients without left ventricular obstruction at rest, the iso•
volumic relaxation period was inversely related to the peak 
filling rate, while no correlation was present in patients with 
obstruction. A similar correlation between duration of iso-
volumic relaxation and peak rate of diastolic filling was 
observed by Sanderson et al. (1) in a group of patients with 
hypertrophic cardiomyopathy, most of whom had no ob•
struction at rest. Prolonged isovolumic relaxation was also 
associated with lengthening of time to peak filling rate com•
pared with normal values. It is noteworthy, however, that 
the temporal delay of peak filling rate in hypertrophic car•
diomyopathy was caused primarily by prolongation of the 
isovolumic period (Table 1). That is, the time interval be•
tween the onset of rapid filling and the peak rate of rapid 
filling did not differ between patients with hypertrophic 
cardiomyopathy and normal subjects. Further evidence for 
this conclusion is provided by analysis of the effects of 
verapamil. A decrease in time to peak filling rate after ve•
rapamil resulted from shortening of the isovolumic period, 
whereas the time interval between end of isovolumic relax•
ation and occurrence of peak rate of filling was unaltered 
(Table 2). 
Effect of verapamil. Intravenous verapamil administra•
tion to patients with hypertrophic cardiomyopathy shortens 
isovolumic relaxation (3). In the present study, oral therapy 
with verapamil led to similar results: the isovolumic period 
decreased in association with improved indexes of rapid 
diastolic filling (9-11). Verapamil therapy had different ef•
fects on the isovolumic relaxation period depending on whether 
its control value was prolonged (greater than 1 SD above 
the mean normal value). In patients with a prolonged iso•
volumic relaxation period, this period was significantly 
shortened by the drug, whereas in patients with a normal 
or short isovolumic period, this time interval increased after 
verapamil therapy (Fig. 3). 
These different responses to verapamil may possibly be 
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explained by the relation between isovolumic relaxation and 
left ventricular outflow tract obstruction and by the potential 
for verapamil to decrease the outflow gradient (22,23). We 
have observed that the isovolumic relaxation period is shorter 
in patients with a significant left ventricular outflow tract 
gradient than in patients without a gradient (Table 1). This 
finding is consistent with data by Alvares et al. (6), who 
found that all patients with a subnormal isovolumic relax•
ation period had a rest or provocable left ventricular outflow 
tract gradient. The mechanism for reduced isovolumic re•
laxation in the setting of left ventricular outflow obstruction 
appears to be prolongation of systolic ejection and delay in 
time to end-systole, rather than an earlier onset of rapid 
filling (Table 1, Fig. 2). Because both systolic pressure and 
ejection timing are important determinants of the rate and 
extent of left ventricular relaxation (24,25), more rapid iso•
volumic relaxation in patients with an outflow gradient might 
be explained by a higher systolic pressure and greater ejec•
tion time than in patients without an outflow gradient. In 
this regard, verapamil prolonged the isovolumic relaxation 
period in patients who manifested normal or short values 
before treatment with verapamil (Fig. 3), and this prolon•
gation was related to a decrease in time to end-systole (Table 
3). These data are compatible with reduction in ejection 
time stemming from verapamil-induced decrease in the se•
verity of the outflow gradient. 
Conclusions. Our findings demonstrate that the left ven•
tricular relaxation period is prolonged in patients with hy•
pertrophic cardiomyopathy and results in impaired and de•
layed left ventricular filling. Prolongation of relaxation, 
however, is not present in all patients because many of those 
with a left ventricular outflow tract gradient at rest have a 
normal or short isovolumic relaxation period that may be 
related to altered systolic loading conditions. Verapamil 
therapy decreases the duration of isovolumic relaxation in 
association with improved diastolic filling characteristics. 
These data indicate that altered relaxation is an important 
determinant of decreased left ventricular filling in hyper•
trophic cardiomyopathy. 
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